West Pharma exec says Q3 HVP device growth rate may not repeat in Q4
A West Pharma executive said during a conference call that the Q3 HVP device growth rate is not expected to repeat in Q4.
A West Pharma executive said during a conference call that the Q3 HVP device growth rate is not expected to repeat in Q4.